Flagship, Offspring partner to provide assay development services

Create PDF

February 2024—Flagship Biosciences and Offspring Biosciences announced a strategic partnership to provide a comprehensive suite of preclinical and clinical services. The partnership allows the companies to leverage their combined expertise in preclinical and clinical trial assays to provide their drug development partners an end-to-end solution within North America and Europe.

Flagship Biosciences, 303-325-5894
Offspring Biosciences, +46732020307